The Present and FutureJACC State-of-the-Art ReviewInterpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review
JACC State-of-the-Art Review
Under a Creative Commons license
open access
Central Illustration
Key Words
clinical care
clinical trials
KCCQ
quality of life
Abbreviations and Acronyms
CI
confidence interval
FDA
U.S. Food and Drug Administration
HFpEF
heart failure with preserved ejection fraction
HFrEF
heart failure with reduced ejection fraction
KCCQ
Kansas City Cardiomyopathy Questionnaire
MCID
minimal clinically important difference
METs
metabolic equivalents
NNT
number-needed-to-treat
NYHA
New York Heart Association
Cited by (0)
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.
© 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.